TPCW
MEDP icon

TD Private Client Wealth’s Medpace MEDP Stock Holding History

TD Private Client Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.2K Buy
167
+2
+1% +$1.02K ﹤0.01% 797
2025
Q4 		$92.7K Sell
165
-44
-21% -$25K ﹤0.01% 776
2025
Q3 		$107K Sell
209
-56
-21% -$24.4K ﹤0.01% 742
2025
Q2 		$83.2K Hold
265
– – ﹤0.01% 760
2025
Q1 		$80.7K Sell
265
-150
-36% -$50.5K ﹤0.01% 731
2024
Q4 		$138K Sell
415
-53
-11% -$18K ﹤0.01% 671
2024
Q3 		$156K Sell
468
-50
-10% -$19K ﹤0.01% 654
2024
Q2 		$213K Sell
518
-23
-4% -$9.11K 0.01% 558
2024
Q1 		$219K Sell
541
-34
-6% -$12K 0.01% 570
2023
Q4 		$176K Sell
575
-106
-16% -$28.6K 0.01% 595
2023
Q3 		$165K Sell
681
-182
-21% -$46.5K 0.01% 576
2023
Q2 		$207K Buy
863
+78
+10% +$16.2K 0.01% 554
2023
Q1 		$148K Sell
785
-127
-14% -$26.3K 0.01% 589
2022
Q4 		$194K Buy
912
+18
+2% +$3.6K 0.01% 545
2022
Q3 		$141K Buy
894
+310
+53% +$49.5K 0.01% 574
2022
Q2 		$87.4K Sell
584
-14
-2% -$2.03K ﹤0.01% 633
2022
Q1 		$97.8K Buy
+598
New +$98.6K ﹤0.01% 642

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TD Private Client Wealth's MEDP Position: Q1 2026 in Review

TD Private Client Wealth increased its Medpace (MEDP) stake by 1.2% in Q1 2026, buying an estimated $1.02K and bringing the position to 167 shares worth $80.2K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

TD Private Client Wealth first reported a position in MEDP in Q1 2022 and has held it in 17 quarters since. The position peaked at $219K in Q1 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • TD Private Client Wealth held 167 shares of Medpace worth $80.2K as of Q1 2026.
  • TD Private Client Wealth bought 2 Medpace shares in Q1 2026, an estimated $1.02K.
  • Medpace made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #797 holding.
  • TD Private Client Wealth first reported a position in Medpace in Q1 2022 and has held it in 17 quarters since.
  • TD Private Client Wealth's Medpace position peaked at $219K in Q1 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.